Intercept's NASH decision date is deferred; EMA investigates safety of LEO Pharma gel
→ The first drugmaker tipped to win approval for a NASH therapeutic is going to have to wait three months longer. The FDA is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
